Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2006

01-09-2006 | Original Paper

Helicobacter pylori Infection Is the Major Risk Factor for Gastric Inflammation in the Cardia

Authors: Yasuo Egi, Sunjin Kim, Masanori Ito, Shinji Tanaka, Masaharu Yoshihara, Ken Haruma, Kazuaki Chayama

Published in: Digestive Diseases and Sciences | Issue 9/2006

Login to get access

Abstract

We attempted to clarify the pathogenesis of gastric inflammation in the cardia. Eighty Japanese participated in this study. Biopsy specimens of the gastric antrum, corpus, and cardia (1 cm from the squamocolumnar junction) were obtained, and histological gastritis was evaluated. Cardiac inflammation was also evaluated using magnifying gastroscopy. We examined Helicobacter pylori infection, gastric juice pH/bile acid (BA), serum pepsinogen and gastrin levels, gastroesophageal reflux disease (GERD), and habitual smoking and assessed the relations between these factors and cardiac inflammation. The prevalence of H. pylori infection was statistically higher in patients with cardiac inflammation than in those without inflammation (P < 0.05). The relationship was also demonstrated by magnifying gastroscopy. Cardiac inflammation was linked to low acid output but not linked to the BA concentration or habitual smoking. Cardiac inflammation was more pronounced in patients without GERD. These results suggest that H. pylori is a major risk factor for cardiac inflammation in the Japanese.
Literature
1.
go back to reference Correa P (1995) Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 19(Suppl 1):S37–S43PubMed Correa P (1995) Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 19(Suppl 1):S37–S43PubMed
2.
go back to reference Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G (1996) Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 91:959–962PubMed Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G (1996) Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 91:959–962PubMed
3.
go back to reference Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K, Kajiyama G, Talley NJ (1998) Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol 93:1271–1276CrossRefPubMed Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K, Kajiyama G, Talley NJ (1998) Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol 93:1271–1276CrossRefPubMed
4.
go back to reference Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789CrossRefPubMed Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789CrossRefPubMed
5.
go back to reference Sasazuki S, Sasaki S, Tsugane S Japan Public Health Center Study Group (2002) Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer 101(6):560–566CrossRefPubMed Sasazuki S, Sasaki S, Tsugane S Japan Public Health Center Study Group (2002) Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer 101(6):560–566CrossRefPubMed
6.
go back to reference Huang JQ, Sridhar S, Chen Y, Hunt RH (1998) Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114(6):1169–1179CrossRefPubMed Huang JQ, Sridhar S, Chen Y, Hunt RH (1998) Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114(6):1169–1179CrossRefPubMed
7.
go back to reference Graham DY, Opekun AR, Yamaoka Y, Osato MS, el-Zimaity HM (2003) Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther 17(2):193–200CrossRefPubMed Graham DY, Opekun AR, Yamaoka Y, Osato MS, el-Zimaity HM (2003) Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther 17(2):193–200CrossRefPubMed
8.
go back to reference Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Festen HP, Dent J, Zeitoun P, Havu N, Lamm M, Walan A (2004) Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 53(1):12–20CrossRefPubMed Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Festen HP, Dent J, Zeitoun P, Havu N, Lamm M, Walan A (2004) Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 53(1):12–20CrossRefPubMed
9.
go back to reference Dixon MF, Genta RM, Yardley JH, Correa P, participants in International Workshop on the Histopathology of Gastritis, Houston, 1994 (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis. Am J Surg Pathol 20:1161–1181CrossRefPubMed Dixon MF, Genta RM, Yardley JH, Correa P, participants in International Workshop on the Histopathology of Gastritis, Houston, 1994 (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis. Am J Surg Pathol 20:1161–1181CrossRefPubMed
10.
go back to reference Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L (1996) The endoscopic assessment of esophagitis: a progresss report on observer agreement. Gastroenterology 111:85–92CrossRefPubMed Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L (1996) The endoscopic assessment of esophagitis: a progresss report on observer agreement. Gastroenterology 111:85–92CrossRefPubMed
11.
go back to reference Nakamura M, Haruma K, Kamada T, Mihara M, Yoshihara M, Imagawa M, Kajiyama G (2001) Duodenogastric reflux is associated with antral metaplastic gastritis. Gastrointest Endosc 53:53–59CrossRefPubMed Nakamura M, Haruma K, Kamada T, Mihara M, Yoshihara M, Imagawa M, Kajiyama G (2001) Duodenogastric reflux is associated with antral metaplastic gastritis. Gastrointest Endosc 53:53–59CrossRefPubMed
12.
go back to reference Kim S, Haruma K, Ito M, Tanaka S, Yoshihara M, Chayama K (2004) Magnifying gastroendoscopy for diagnosis of histologic gastritis in the gastric antrum. Dig Liver Dis 36(4):286–291CrossRefPubMed Kim S, Haruma K, Ito M, Tanaka S, Yoshihara M, Chayama K (2004) Magnifying gastroendoscopy for diagnosis of histologic gastritis in the gastric antrum. Dig Liver Dis 36(4):286–291CrossRefPubMed
13.
go back to reference Sakaki N, Iida Y, Saito M, Tada M, Odawara M, Okazaki Y (1980) New magnifying endoscopic classification of the fine gastric mucosal pattern. Gastroenterol Endosc 22:377–383 Sakaki N, Iida Y, Saito M, Tada M, Odawara M, Okazaki Y (1980) New magnifying endoscopic classification of the fine gastric mucosal pattern. Gastroenterol Endosc 22:377–383
14.
go back to reference Siewert JR, Stein HJ (1996) Carcinoma of the cardia: Carcinoma of the gastroesophageal junction—classification, pathology and extent of resection. Dis Esophagus 9:173–182 Siewert JR, Stein HJ (1996) Carcinoma of the cardia: Carcinoma of the gastroesophageal junction—classification, pathology and extent of resection. Dis Esophagus 9:173–182
15.
go back to reference Glickman JN, Fox V, Antonioli DA, Wang HH, Odze RD (2002) Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol 26:1032–1039CrossRefPubMed Glickman JN, Fox V, Antonioli DA, Wang HH, Odze RD (2002) Morphology of the cardia and significance of carditis in pediatric patients. Am J Surg Pathol 26:1032–1039CrossRefPubMed
16.
go back to reference Chandrasoma P (2003) Histopathology of the gastroesophageal junction: a study on 36 operation specimens. Am J Surg Pathol 27(2):277–278CrossRefPubMed Chandrasoma P (2003) Histopathology of the gastroesophageal junction: a study on 36 operation specimens. Am J Surg Pathol 27(2):277–278CrossRefPubMed
17.
go back to reference Yagi K, Nakamura A, Sekine A (2004) Intestinal metaplasia of gastric cardia and carditis in Japanese patients with Helicobacter pylori infection. Digestion 70(2):103–108CrossRefPubMed Yagi K, Nakamura A, Sekine A (2004) Intestinal metaplasia of gastric cardia and carditis in Japanese patients with Helicobacter pylori infection. Digestion 70(2):103–108CrossRefPubMed
18.
go back to reference McNamara D, Buckley M, Crotty P, Hall W, O’Sullivan M, O’Morain C (2002) Carditis: All Helicobacter pylori or is there a role for gastro-oesophageal reflux? Scand J Gastroenterol 37:772–777PubMedCrossRef McNamara D, Buckley M, Crotty P, Hall W, O’Sullivan M, O’Morain C (2002) Carditis: All Helicobacter pylori or is there a role for gastro-oesophageal reflux? Scand J Gastroenterol 37:772–777PubMedCrossRef
19.
go back to reference Ayhan S, Demir MA, Kandiloglu AR, Saruc M, Kucukmetin N (2003) Features of chronic inflammation at the gastric cardia and the relationship with Helicobacter pylori infection and oesophagitis. Acta Gastroenterol Belg 66:144–149PubMed Ayhan S, Demir MA, Kandiloglu AR, Saruc M, Kucukmetin N (2003) Features of chronic inflammation at the gastric cardia and the relationship with Helicobacter pylori infection and oesophagitis. Acta Gastroenterol Belg 66:144–149PubMed
20.
go back to reference Pieramico O, Zanetti MV (2000) Relationship between intestinal metaplasia of the gastro-oesophageal junction, Helicobacter pylori infection and gastro-oesophageal reflux disease: a prospective study. Dig Liver Dis 32:567–572CrossRefPubMed Pieramico O, Zanetti MV (2000) Relationship between intestinal metaplasia of the gastro-oesophageal junction, Helicobacter pylori infection and gastro-oesophageal reflux disease: a prospective study. Dig Liver Dis 32:567–572CrossRefPubMed
21.
go back to reference Morini S, Zullo A, Hassan C, Lorenzetti R, Stella F, Martini MT (2001) Gastric cardia inflammation: role of Helicobacter pylori infection and symptoms of gastroesophageal reflux disease. Am J Gastroenterol 96:2337–2340CrossRefPubMed Morini S, Zullo A, Hassan C, Lorenzetti R, Stella F, Martini MT (2001) Gastric cardia inflammation: role of Helicobacter pylori infection and symptoms of gastroesophageal reflux disease. Am J Gastroenterol 96:2337–2340CrossRefPubMed
22.
go back to reference Goldblum JR, Richter JE, Vaezi M, Falk GW, Rice TW, Peek RM (2002) Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Am J Gastroenterol 97:302–311CrossRefPubMed Goldblum JR, Richter JE, Vaezi M, Falk GW, Rice TW, Peek RM (2002) Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Am J Gastroenterol 97:302–311CrossRefPubMed
23.
go back to reference Jang TJ, Kim NI, Yang CH (2003) Carditis is associated with Helicobacter pylori-induced gastritis and not reflux esophagitis. J Clin Gastroenterol 36(1):26–29CrossRefPubMed Jang TJ, Kim NI, Yang CH (2003) Carditis is associated with Helicobacter pylori-induced gastritis and not reflux esophagitis. J Clin Gastroenterol 36(1):26–29CrossRefPubMed
24.
go back to reference Der R, Tsao-Wei DD, Demeester T, Peters J, Groshen S, Lord RV, Chandrasoma P (2001) Carditis; a manifestation of gastroesophageal reflux disease. Am J Surg Pathol 25:245–252PubMedCrossRef Der R, Tsao-Wei DD, Demeester T, Peters J, Groshen S, Lord RV, Chandrasoma P (2001) Carditis; a manifestation of gastroesophageal reflux disease. Am J Surg Pathol 25:245–252PubMedCrossRef
25.
go back to reference Hatakeyama M (2004) Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 4(9):688–694CrossRefPubMed Hatakeyama M (2004) Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 4(9):688–694CrossRefPubMed
26.
go back to reference Sharma P, Topalovski M, Mayo MS, Sampliner RE, Weston AP (2000) Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia. Am J Gastroenterol 95:3107–3111CrossRefPubMed Sharma P, Topalovski M, Mayo MS, Sampliner RE, Weston AP (2000) Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia. Am J Gastroenterol 95:3107–3111CrossRefPubMed
Metadata
Title
Helicobacter pylori Infection Is the Major Risk Factor for Gastric Inflammation in the Cardia
Authors
Yasuo Egi
Sunjin Kim
Masanori Ito
Shinji Tanaka
Masaharu Yoshihara
Ken Haruma
Kazuaki Chayama
Publication date
01-09-2006
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-005-9046-4

Other articles of this Issue 9/2006

Digestive Diseases and Sciences 9/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.